CIK: 0002039349 · Show all filings
Period: Q4 2025
Filing Date: Feb 17, 2026
Total Value ($000): $139,493 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KYTX | KYVERNA THERAPEUTICS INC | 4,391,818 | $41,283 | 29.6% | $7.42 | 0.0% | COM | 501976104 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 769,550 | $24,018 | 17.2% | $31.21 | — | SPONSORED ADS | 881624209 |
| BLCO | BAUSCH PLUS LOMB CORP | 613,472 | $10,478 | 7.5% | $15.86 | 0.0% | COMMON SHARES | 071705107 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 224,135 | $10,433 | 7.5% | $44.52 | 0.0% | COM | 22663K107 |
| AMGN | AMGEN INC | 23,212 | $7,598 | 5.4% | $315.95 | 0.0% | COM | 031162100 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 329,101 | $7,569 | 5.4% | $32.88 | 0.0% | COM | 90400D108 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,330,901 | $7,320 | 5.2% | $4.86 | 0.0% | COM SHS | 877619106 |
| VIR | VIR BIOTECHNOLOGY INC | 930,317 | $5,610 | 4.0% | $5.95 | 0.0% | COM | 92764N102 |
| TARS | TARSUS PHARMACEUTICALS INC | 66,680 | $5,460 | 3.9% | $74.67 | 0.0% | COM | 87650L103 |
| INCY | INCYTE CORP | 54,500 | $5,383 | 3.9% | $96.76 | 0.0% | COM | 45337C102 |
| INSM | INSMED INC | 28,587 | $4,975 | 3.6% | $182.48 | 0.0% | COM PAR $.01 | 457669307 |
| PYXS | PYXIS ONCOLOGY INC | 4,121,870 | $4,740 | 3.4% | $3.53 | 0.0% | COM NEW | 747324101 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 170,307 | $4,626 | 3.3% | $26.34 | 0.0% | COM NEW | 15117B202 |